Femoral Nerve Block vs Peri-capsular Nerve Group Block for Hip Fracture Analgesia

Sponsor
Antalya Training and Research Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05444803
Collaborator
(none)
52
2
3

Study Details

Study Description

Brief Summary

The purpose of the study is to compare the analgesic efficacy of femoral nerve block and peri-capsular nerve group block administered before spinal anesthesia for positioning to spinal anaesthesia in patients undergoing surgery for hip fracture and to evaluate the efficacy for postoperative analgesia

Condition or Disease Intervention/Treatment Phase
  • Other: femoral nerve block
  • Other: peri-capsular nerve group block
N/A

Detailed Description

Spinal anesthesia is commonly used in patients undergoing hip fracture surgery. However the procedure of patient positioning to perform a spinal block is painful and may require the administration of IV analgesics or some regional anesthesia techniques such as femoral nerve block, fascia-iliaca compartment block, peri-capsular nerve group block. At the study, the investigators aimed to compare analgesic efficacy of femoral nerve block and peri-capsular nerve group block administered before spinal anesthesia for positioning to spinal anaesthesia in patients undergoing surgery for hip fracture and to evaluate the efficacy for postoperative analgesia.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
52 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Other
Official Title:
Comparison of Femoral Nerve Block Versus Peri-capsular Nerve Group Block for Analgesia During Positioning for Spinal Anesthesia in Patients With Hip Fracture
Anticipated Study Start Date :
Jul 1, 2022
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Oct 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Other: Femoral nerve block group

Thirty minutes before the placement of spinal block, patients will be receive a femoral nerve block.

Other: femoral nerve block
Patients will be performed a femoral nerve block thirty minutes before the performing of spinal block.

Other: Peri-capsular nerve group block group

Thirty minutes before the placement of spinal block, patients will be receive a peri-capsular nerve group block

Other: peri-capsular nerve group block
Patients will be performed a peri-capsular nerve group block thirty minutes before the performing of spinal block.

Outcome Measures

Primary Outcome Measures

  1. pain scores assessed by Numerical rating Score Scale during positioning for spinal anesthesia [30 minutes]

    Pain scores will be assessed by Numerical Rating Scale (NRS) scores (from 0=no pain to 10=maximum possible pain).

Secondary Outcome Measures

  1. Pain scores at rest [30 min]

    Pain scores will be assessed by Numerical Rating Scale (NRS) scores from 0 (no pain) to 10 (maximum possible pain) at rest before and 30 min after the block performance.

  2. Pain scores on passive limb lifting [30 min]

    Pain scores will be assessed by Numerical Rating Scale (NRS) scores from 0 (no pain) to 10 (maximum possible pain) on passive limb lifting before and 30 min after the block performance.

  3. postoperative pain scores [24 hours]

    Pain scores will be assessed by Numerical Rating Scale (NRS) scores from 0 (no pain) to 10 (maximum possible pain).at 6, 12, 24 hours postoperatively.

  4. postoperative analgesic consumption [24 hours]

    Postoperative analgesic consumption will be recorded for postoperative 24 hours

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients with hip fracture scheduled for surgery under spinal anesthesia.
Exclusion Criteria:
  • hemorrhagic diathesis,

  • peripheral neuropathy,

  • allergy to local anesthetics,

  • mental disorders,

  • use of analgesics for 8 h before the performance of spinal block

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Antalya Training and Research Hospital

Investigators

  • Principal Investigator: Safa Eroglu, M.D., Antalya Traning and Research Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Antalya Training and Research Hospital
ClinicalTrials.gov Identifier:
NCT05444803
Other Study ID Numbers:
  • safa1
First Posted:
Jul 6, 2022
Last Update Posted:
Jul 6, 2022
Last Verified:
Jun 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 6, 2022